Hervé Tilly, MD¹, Franck Morschhauser, MD, PhD^2*, Laurie H. Sehn, MD³, Jonathan W. Friedberg, MD ⁴, Marek Trněný, MD⁵, Jeff P. Sharman, MD⁶, Charles Herbaux, MD⁷, John M. Burke, MD⁸, Matthew Matasar, MD^9,10, Shinya Rai, MD, PhD^11*, Koji Izutsu, MD, PhD^12*, Neha Mehta-Shah, MD¹³, Lucie Oberic, MD^14*, Adrien Chauchet, MD^15*, Wojciech Jurczak, PhD, MD¹⁶, Yuqin Song, MD^17*, Richard Greil, MD¹⁸, Larysa Mykhalska, MD^19*, Juan Miguel Bergua Burgués, MD^20*, Matthew C. Cheung, MD²¹, Antonio Pinto, MD^22*, Ho-Jin Shin, MD, PhD^23*, Greg Hapgood, MD, PhD^24*, Eduardo Munhoz, MD^25*, Pau Abrisqueta Costa, MD, PhD^26*, Jyh-Pyng Gau, MD^27*, Jamie Hirata, PharmD²⁸, Yanwen Jiang, PhD^28*, Mark Yan, PhD^29*, Calvin Lee, MD²⁸, Christopher R. Flowers, MD³⁰ and Gilles Salles, MD, PhD³¹

¹Department of Hematology and U1245, Centre Henri Becquerel and University of Rouen, Rouen, France
²Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France
³BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada
⁴Wilmot Cancer Institute, University of Rochester, Rochester, NY
⁵First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
⁶Willamette Valley Cancer Institute/US Oncology, Eugene, OR
⁷CHU de Montpellier, Montpellier, France
⁸Rocky Mountain Cancer Centers/US Oncology, Aurora, CO
⁹Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Memorial Sloan Kettering Cancer Center, Montvale, NJ
¹¹Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine, Osaka-Sayama City, Japan
¹²National Cancer Center Hospital, Tokyo, Japan
¹³Washington University in St. Louis, St. Louis, MO
¹⁴Department of Hematology, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France
¹⁵Department of Hematology, CHRU Besançon, Besançon, France
¹⁶Maria Skłodowska – Curie National Research Institute of Oncology, Kraków, Poland
¹⁷Peking University Cancer Hospital, Beijing, China
¹⁸3rd Medical Department, Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT and Cancer Cluster Salzburg, Salzburg, Austria
¹⁹Clinical Hospital Feofaniya, Kyiv, Ukraine
²⁰Hospital San Pedro de Alcántara, Cáceres, Spain
²¹Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
²²Hematology-Oncology & Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
²³Division of Hematology-Oncology, Department of Internal Medicine, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea, Republic of (South)
²⁴Princess Alexandra Hospital, Brisbane, QLD, Australia
²⁵Hospital Erasto Gaertner, Curitiba, Brazil
²⁶Department of Hematology, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
²⁷Taipei Veterans General Hospital, Taipei, Taiwan
²⁸Genentech, Inc., South San Francisco, CA
²⁹F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada
³⁰MD Anderson Cancer Center, Houston, TX
³¹Memorial Kettering Cancer Center, New York, NY

Alok Srivastava, MD, FRACP, FRCPA, FRCP¹, Savita Rangarajan, MBBS, MD, FRCP, FRCPath², Kaan Kavakli, MD, PhD^3*, Robert Klamroth, MD^4*, Gili Kenet, MD⁵, Liane Khoo, MD, MBBS, PhD, FRACP, FRCPA^6*, Chur-Woo You, MD, PhD^7*, Weiqun Xu, MD, PhD^8*, Niel Malan, MD^9*, Laurent Frenzel, MD, PhD¹⁰, Catherine N. Bagot, MD, FRCPath, MBBS^11*, Oleksandra Stasyshyn, MD, PhD^12*, Chia-Yau Chang, MD^13*, Stacey Poloskey, MD^14*, Shauna Andersson, MD, PhD^15*, Zhiying Qiu, PhD^16*, Baisong Mei, MD, PhD^15* and Steven W. Pipe, MD¹⁷

¹Department of Hematology, Christian Medical College, Vellore, India
²KJ Somaiya Super Specialty Hospital, Mumbai, India
³Department of Hematology, Ege University Faculty of Medicine, Children's Hospital, Izmir, Turkey
⁴Department for Internal Medicine and Vascular Medicine, Haemophilia Treatment Centre, Vivantes Hospital im Friedrichshain, Berlin, Berlin, Germany
⁵The National Haemophilia Centre, The Amalia Biron Thrombosis Research Institute, Sheba Medical Centre, Tel Hashomer, Israel
⁶Haematology Department, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia
⁷Department of Pediatrics, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea, Republic of (South)
⁸Department of Hematology and Oncology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
⁹Phoenix Pharma, Port Elizabeth, South Africa
¹⁰Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, Paris, France
¹¹Department of Haematology, Glasgow Royal Infirmary, Glasgow, United Kingdom
¹²Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine
¹³Division of Pediatric Hematology/Oncology, Hemophilia Center, Taipei Medical University Hospital, Taipei, Taiwan
¹⁴Sanofi, Waltham, MA
¹⁵Sanofi, Cambridge, MA
¹⁶Sanofi, Bridgewater, NJ
¹⁷Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI

Margarete A Fabre^1,2,3*, Jose Guillherme de Almeida^4*, Edoardo Fiorillo^5*, Emily Mitchell^1,3,6*, Aristi Damaskou^1,3*, Justyna Rak^1,3*, Valeria Orru^5*, Michele Marongiu^5*, MS Vijayabaskar^1*, Joanna E Baxter^3*, Claire Hardy^6*, Federico Abascal^6*, Michael Spencer Chapman^1,3,6*, Nicholas Williams^1,6*, Jyoti Nangalia, MBBChir^1,3,7, Inigo Martincorena^6*, Peter J Campbell^1,6*, Eoin F Mckinney^8*, Francesco Cucca^5,9*, Moritz Gerstung^4* and George S Vassiliou, FRCPath, MRCP, PhD, MBBS^1,3,6

¹University of Cambridge, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom
²Wellcome Sanger Institute, Cambridge, ENG, United Kingdom
³University of Cambridge, Department of Haematology, Cambridge, United Kingdom
⁴European Bioinformatics Institute, Cambridge, United Kingdom
⁵Consiglio Nazionale delle Ricerche, Istituto di Ricerca Genetica e Biomedica, Lanusei, Italy
⁶Wellcome Sanger Institute, Cambridge, United Kingdom
⁷Wellcome Sanger Institute, Saffron Walden, ENG, United Kingdom
⁸University of Cambridge, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, United Kingdom
⁹Università degli Studi di Sassari, Dipartimento di Scienze Biomediche, Sassari, Italy

Masayuki Umeda, MD^1*, Jing Ma, PhD^1*, Benjamin J. Huang, MD^2*, Kohei Hagiwara, MD^3*, Tamara Westover, BS^1*, Sherif Abdelhamed, PhD¹, Juan Martin Barajas, PhD¹, Melvin Edward Thomas III, PhD^1*, Michael P Walsh, PhD^1*, Guangchun Song^1*, Liqing Tian, Ph.D^3*, Yanling Liu, PhD^3*, Xiaolong Chen, PhD^3*, Pandurang Kolekar, Ph.D^3*, Quang Tran, PhD^3*, Scott Foy, PhD^3*, Jamie L. Maciaszek, PhD^1*, Andrew B Kleist, MD, PhD^4*, Amanda R. Leonti, MS^5*, Bensheng Ju, PhD^3*, John Easton, PhD^3*, Huiyun Wu, PhD^6*, Virginia Valentine^7*, Marc Valentine, BA^7*, Yen-Chun Liu^1*, Rhonda E. Ries, MA^5*, Jenny L. Smith, MSc, MEd^5*, Evan Parganas^1*, Ilaria Iacobucci, PhD¹, Ryan Hiltenbrand, MS^1*, Jonathan Miller, MD, PhD⁸, Jason Myers^9*, Evadnie Rampersaud, PhD^9*, Delaram Rahbarinia, MSc^3*, Michael Rusch, BS^3*, Gang Wu, PhD^9*, Hiroto Inaba, MD, PhD⁸, Yi-Cheng Wang, MS^10*, Todd A. Alonzo, PhD^11*, James R. Downing, MD¹, Charles G. Mullighan, MBBS, MD¹, Stanley B Pounds, PhD^6*, M. Madan Babu, PhD^12*, Jinghui Zhang, PhD^3*, Jeffrey E. Rubnitz, MD⁸, Soheil Meshinchi, M.D., Ph.D.⁵, Xiaotu Ma, PhD^3* and Jeffery M. Klco, MD, PhD¹

¹Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
²UCSF, San Francisco, CA
³Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
⁴Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI
⁵Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
⁷Cytogenetics, St. Jude Children's Research Hospital, Memphis, TN
⁸Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
⁹Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN
¹⁰Children's Oncology Group, Monrovia, CA
¹¹Department of Preventive Medicine, University of Southern California, Monrovia, CA
¹²Department of Structural Biology and the Center for Data Driven Discovery, St. Jude Children’s Research Hospital, Memphis, TN

Lynn Malec¹, An Van Damme², Anthony Chan³, Mariya Spasova^4*, Nisha Jain⁵, Charlotte Sensinger^5*, Jennifer Dumont^5*, Stefan Lethagen^6*, Manuel Carcao⁷ and Flora Peyvandi^8,9

¹Versiti Blood Research Institute, Milwaukee, WI
²Paediatric Hémato-oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
³Pediatrics, McMaster Children's University, Hamilton, ON, Canada
⁴UMHAT Sv Georgi, EAD, Bulgaria
⁵Sanofi, Cambridge, MA
⁶Sobi, Stockholm, Sweden
⁷The Hospital for Sick Children, Toronto, ON, Canada
⁸Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
⁹Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Michael R. Bishop, MD¹, Michael Dickinson, MBBS², Duncan Purtill^3*, Pere Barba, MD, PhD^4*, Armando Santoro^5*, Nada Hamad⁶, Koji Kato, MD, PhD⁷, Anna Sureda⁸, Richard Greil, MD⁹, Catherine Thieblemont, MD, PhD¹⁰, Franck Morschhauser, MD, PhD^11*, Martin Janz^12*, Ian W. Flinn, MD, PhD¹³, Werner Rabitsch^14*, Yok Lam Kwong^15*, Marie José Kersten, MD, PhD¹⁶, Monique C. Minnema, MD¹⁷, Harald Holte, MD, PhD¹⁸, Esther Hian Li Chan^19*, Joaquin Martinez-Lopez^20*, Antonia MS Mueller, MD²¹, Richard T. Maziarz, MD²², Joseph P. McGuirk, DO²³, Emmanuel Bachy, MD, PhD^24*, Steven Le Gouill²⁵, Martin Dreyling, MD²⁶, Hideo Harigae, MD, PhD²⁷, David A. Bond, MD, BS²⁸, Charalambos Andreadis, MD, MS²⁹, Peter A. McSweeney, MD¹³, Mohamed A. Kharfan-Dabaja, MD, MBA³⁰, Simon Newsome^31*, Evgeny Degtyarev^31*, Chris Del Corral, PharmD^32*, Giovanna Andreola, MD^31*, Aisha Masood, MD³², Stephen J Schuster, MD³³, Ulrich Jaeger³⁴, Peter Borchmann, MD³⁵ and Jason R. Westin, MD³⁶

¹The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
²Peter MacCallum Cancer Centre and Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia
³Fiona Stanley Hospital, Murdoch, Western Australia, Australia
⁴Hospital Universitari Vall d’Hebron and Universitat Autonoma de Barcelona, Barcelona, Spain
⁵Department of Biomedical Sciences, Humanitas University and IRCCS Humanitas Research Hospital-Humanitas Cancer Center, Milan, Italy
⁶Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
⁷Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
⁸Clinical Hematology Department, Institut Català d’Oncologia – Hospitalet de Llobregat, Barcelona, Spain
⁹Third Medical Department, Paracelsus Medical University; Salzburg Cancer Research Institute-CCCIT and Cancer Cluster Salzburg, Salzburg, Austria
¹⁰APHP, Hemato-Oncology, Hôpital Saint-Louis, Paris, France
¹¹Centre Hospitalier Régional Universitaire de Lille, Lille, France
¹²Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Benjamin Franklin, Berlin, Germany
¹³Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN
¹⁴Internal Medicine I, BMT-Unit, Vienna General Hospital-Medical University of Vienna, Vienna, Austria
¹⁵Department of Medicine, Queen Mary Hospital, Hong Kong, China
¹⁶Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
¹⁷Universitair Medisch Centrum Utrecht, Dept Medical Oncology, Utrecht, Netherlands
¹⁸Department of Oncology, Oslo University Hospital, Oslo, Norway
¹⁹National University Cancer Institute, Signapore, Singapore
²⁰Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
²¹Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
²²Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
²³Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
²⁴Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
²⁵CRCINA, INSERM and Nantes Medical University, Nantes, France
²⁶Medizinische Klinik III, LMU Klinikum, Munich, Germany
²⁷Tohoku University Hospital, Sendai, Japan
²⁸The Ohio State University, Columbus, OH
²⁹Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
³⁰Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL
³¹Novartis Pharma AG, Basel, Switzerland
³²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³⁴Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Vienna General Hospital – Medical University of Vienna, Vienna, Austria
³⁵Clinic I for Internal Medicine, University Hospital Cologne, Cologne, Germany
³⁶Department of Lymphoma & Myeloma, M.D. Anderson Cancer Center, Houston, TX